
Day 3 Recap: Fall Clinical Dermatology Conference for PAs and NPs 2025
Key Takeaways
- Chronic hand eczema remains challenging to diagnose and treat, but emerging JAK inhibitors offer promising therapeutic options.
- GLP-1 receptor agonists are being explored as adjunctive treatments in psoriatic disease, providing new therapeutic avenues.
Catch up on coverage from the third day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.
To stay informed with the latest conference insights,
Chronic hand eczema poses diagnostic challenges and impacts quality of life, but emerging JAK inhibitors offer promising new treatment options.
Ben Lockshin, MD, FAAD, covered ways in which GLP-1 RA's can be utilized when treating psoriatic disease.
Discover the latest advancements in aesthetics as Heather Gates, PA-C, shares innovative techniques and emerging technologies from this groundbreaking workshop.
Discover innovative strategies for AK treatment from Darrell Rigel, MD, MS, at the latest Fall Clinical PA/NP conference.
Stay tuned to Dermatology Times all weekend for
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















